Emcure Pharmaceuticals Unlisted Shares Share Price
About The Company
Emcure Pharmaceuticals Unlisted Shares Unlisted Shares
Financials · IPO timeline · Growth projects
Pune-based Emcure Pharmaceuticals is India’s largest pharma company, which was incorporated in 1981 by Mr. Satish Mahesh. The company deals in major therapeutic areas and proactively develops, manufactures, and distributes pharma products. The company has earned accolades for offering state-of-the-art healthcare solutions and leveraging advanced technologies. Emcure Pharma is still an unlisted public company whose unlisted shares are available on online trading platforms.
As a retail investor, if you want to diversify your investment portfolio and want to buy Emcure Pharma unlisted shares, you can go through this page to get important details of Emcure Pharma unlisted shares and everything about the company to make wise decisions.
Business Model Of Emcure Pharmaceuticals
Being a global manufacturer of pharmaceutical products, Emcure Pharma is recognised as the 12th largest pharmaceutical company in India. Emcure products are sold in over 70 countries worldwide, having a robust presence in Europe and Canada. The major therapeutic areas where the company’s products are manufactured include:
- Gynaecology
- Neurology
- Oncology
- Cardiology
- Blood-related
- Pain management and analgesics
- Respiratory
- HIV
A Brief SWOT Analysis Of Emcure Pharmaceuticals
To ensure your money is invested in the right company, it is crucial to know its strengths, weaknesses, opportunities, and threats. Knowing the complete SWOT analysis of Emcure Pharma will help you make your investment decision.
Strengths
The strengths of the company include:
- Advanced research and development
- International presence
- Financial standing
- A wide range of pharmaceutical products
- A trusted name in the pharma sector
Weaknesses
Below are the weaknesses of the company:
- Inability to forecast demand for its products
- Does not focus on one market segment
- Not a unique product portfolio
Opportunities
The opportunities of the company are listed below:
- Part of a growing sector
- Integration of advanced technology to manufacture products
- API market push
Threats
The following are the threats to the company:
- Cut-throat competition
- Change in pharmaceutical regulations
- Unsuccessful attempt to innovative driven goals
An Overview Of Emcure Pharma IPO
Like other unlisted share companies, Emcure Pharmaceuticals has decided to join the IPO. The company has filed a Draft Red Herring Prospectus (DRHP) with the Securities Exchange Board of India (SEBI) to raise funds through Initial Public Offerings (IPO) worth Rs. 4000-Rs 5000 Cr. The IPO will comprise a fresh issue of up to Rs. 1100 Cr. by the company. The raised fund will be used as growth capital and an offer for sale (OFS) of 18,168,356 by promoters and existing shareholders - founder, managing director, and chief executive officer Satish Mehta, who owns 41.92% and son Sunil Mehta, who holds 6.13%, with a worldwide presence, including 19 subsidiaries, 500 scientists, and 11,000 employees. With IPO, the company wants to grow their business operations in the pharmaceutical sector. Since the company has not gone public yet, knowing Emcure Pharma share price NSE would be difficult, for which investors have to wait.
Check Emcure Pharma Unlisted Shares At Stockify
Before investing in Emcure Pharma unlisted shares, it is crucial for every retail investor to know the price of unlisted shares of the company. Emcure Pharma pre-IPO share prices fluctuate based on the company’s performance and market trends. To get the right information on the unlisted share prices, you can connect with the expert brokers at Stockify, who will update you with the updated unlisted share prices. On Stockify, you can get information regarding unlisted share prices of top pre-IPO companies in India and make your formed investment decisions. Keep updated with unlisted share prices with Stockify.
Why Choose Stockify To Buy Emcure Pharma Unlisted Shares In India?
Are you on the lookout for a reliable and trustworthy unlisted stock broking platform to buy Emcure Pharma unlisted shares? Stockify is here to help. Being India’s leading online stock trading platform, we help retail investors buy and sell unlisted shares of top pre-IPO companies in India. Trusted by thousands of investors, our experts at Stockify give you detailed information on unlisted shares like EBITDA, EPS Growth, Profit and Loss statements, etc. Further, experts can help you select the best and highest returning shares. Are we still pondering over this? Connect with our expert brokers to know Emcure Pharmaceuticals share price and start trading.
Reliance Retail, Pharmeasy, Chennai Super Kings, Anglo-French Drugs & Industries, Hexaware Technologies Ltd, Five Star Business Finance Ltd Unlisted Shares, Fincare Small Finance Bank Ltd Unlisted Shares, Arohan Financial Services Unlisted Shares, Utkarsh Coreinvest Ltd Unlisted Shares, Fino Paytech Ltd Unlisted Shares, Hero Fincorp Ltd Unlisted Shares, National Stock Exchange Ltd Nse Unlisted Shares, National Commodity Derivatives Exchange Ltd Ncdex Unlisted Shares, MetroPolitan Stock Exchange MSEI Unlisted Shares, Capital, Small Finance Bank Ltd Unlisted Shares, And Motilal Oswal Home Finance Ltd Unlisted Shares
Buy Emcure Pharma Unlisted Share With Stockify!
Strong
Market Position
Consistent
YoY Growth
Experienced
Management
Key Indicators
A snapshot of Emcure Pharmaceuticals Unlisted Shares's financial health, valuation multiples and capital efficiency at a glance.
Pricing Trends
Financial Performance
| Indicators |
|---|
| Revenue |
| Expense |
| EBITDA |
| Other Cost |
| PBT |
| Tax Expense |
| PAT |
| Other Inc./Exp. |
| Net Income |
| Shares O/S |
| EPS (₹) |
| Rev. Growth % |
| EBITDA Mgn % |
| Net Mgn % |
| EPS Growth |
Registered Address
Management Team
Top Unlisted companies
Frequently Asked Questions
Still have questions?
Our expert team typically responds within 30 minutes during market hours.
About Emcure Pharma Unlisted Shares
Pune-based Emcure Pharmaceuticals is India’s largest pharma company, which was incorporated in 1981 by Mr. Satish Mahesh. The company deals in major therapeutic areas and proactively develops, manufactures, and distributes pharma products. The company has earned accolades for offering state-of-the-art healthcare solutions and leveraging advanced technologies. Emcure Pharma is still an unlisted public company whose unlisted shares are available on online trading platforms.
As a retail investor, if you want to diversify your investment portfolio and want to buy Emcure Pharma unlisted shares, you can go through this page to get important details of Emcure Pharma unlisted shares and everything about the company to make wise decisions.
Business Model Of Emcure Pharmaceuticals
Being a global manufacturer of pharmaceutical products, Emcure Pharma is recognised as the 12th largest pharmaceutical company in India. Emcure products are sold in over 70 countries worldwide, having a robust presence in Europe and Canada. The major therapeutic areas where the company’s products are manufactured include:
- Gynaecology
- Neurology
- Oncology
- Cardiology
- Blood-related
- Pain management and analgesics
- Respiratory
- HIV
A Brief SWOT Analysis Of Emcure Pharmaceuticals
To ensure your money is invested in the right company, it is crucial to know its strengths, weaknesses, opportunities, and threats. Knowing the complete SWOT analysis of Emcure Pharma will help you make your investment decision.
Strengths
The strengths of the company include:
- Advanced research and development
- International presence
- Financial standing
- A wide range of pharmaceutical products
- A trusted name in the pharma sector
Weaknesses
Below are the weaknesses of the company:
- Inability to forecast demand for its products
- Does not focus on one market segment
- Not a unique product portfolio
Opportunities
The opportunities of the company are listed below:
- Part of a growing sector
- Integration of advanced technology to manufacture products
- API market push
Threats
The following are the threats to the company:
- Cut-throat competition
- Change in pharmaceutical regulations
- Unsuccessful attempt to innovative driven goals
An Overview Of Emcure Pharma IPO
Like other unlisted share companies, Emcure Pharmaceuticals has decided to join the IPO. The company has filed a Draft Red Herring Prospectus (DRHP) with the Securities Exchange Board of India (SEBI) to raise funds through Initial Public Offerings (IPO) worth Rs. 4000-Rs 5000 Cr. The IPO will comprise a fresh issue of up to Rs. 1100 Cr. by the company. The raised fund will be used as growth capital and an offer for sale (OFS) of 18,168,356 by promoters and existing shareholders - founder, managing director, and chief executive officer Satish Mehta, who owns 41.92% and son Sunil Mehta, who holds 6.13%, with a worldwide presence, including 19 subsidiaries, 500 scientists, and 11,000 employees. With IPO, the company wants to grow their business operations in the pharmaceutical sector. Since the company has not gone public yet, knowing Emcure Pharma share price NSE would be difficult, for which investors have to wait.
Check Emcure Pharma Unlisted Shares At Stockify
Before investing in Emcure Pharma unlisted shares, it is crucial for every retail investor to know the price of unlisted shares of the company. Emcure Pharma pre-IPO share prices fluctuate based on the company’s performance and market trends. To get the right information on the unlisted share prices, you can connect with the expert brokers at Stockify, who will update you with the updated unlisted share prices. On Stockify, you can get information regarding unlisted share prices of top pre-IPO companies in India and make your formed investment decisions. Keep updated with unlisted share prices with Stockify.
Why Choose Stockify To Buy Emcure Pharma Unlisted Shares In India?
Are you on the lookout for a reliable and trustworthy unlisted stock broking platform to buy Emcure Pharma unlisted shares? Stockify is here to help. Being India’s leading online stock trading platform, we help retail investors buy and sell unlisted shares of top pre-IPO companies in India. Trusted by thousands of investors, our experts at Stockify give you detailed information on unlisted shares like EBITDA, EPS Growth, Profit and Loss statements, etc. Further, experts can help you select the best and highest returning shares. Are we still pondering over this? Connect with our expert brokers to know Emcure Pharmaceuticals share price and start trading.
Reliance Retail, Pharmeasy, Chennai Super Kings, Anglo-French Drugs & Industries, Hexaware Technologies Ltd, Five Star Business Finance Ltd Unlisted Shares, Fincare Small Finance Bank Ltd Unlisted Shares, Arohan Financial Services Unlisted Shares, Utkarsh Coreinvest Ltd Unlisted Shares, Fino Paytech Ltd Unlisted Shares, Hero Fincorp Ltd Unlisted Shares, National Stock Exchange Ltd Nse Unlisted Shares, National Commodity Derivatives Exchange Ltd Ncdex Unlisted Shares, MetroPolitan Stock Exchange MSEI Unlisted Shares, Capital, Small Finance Bank Ltd Unlisted Shares, And Motilal Oswal Home Finance Ltd Unlisted Shares
